Vicki L. Goodman - 15 Feb 2023 Form 4 Insider Report for EXELIXIS, INC. (EXEL)

Role
EVP, Prod Dev & Med Aff &CMO
Signature
/s/ Nina Ayer, Attorney in Fact
Issuer symbol
EXEL
Transactions as of
15 Feb 2023
Net transactions value
-$312,766
Form type
4
Filing time
17 Feb 2023, 20:38:05 UTC
Previous filing
06 Jan 2022
Next filing
05 Apr 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EXEL Common Stock Tax liability $312,766 -17,299 -7.1% $18.08 225,088 15 Feb 2023 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares withheld by Exelixis, Inc. to satisfy taxes payable in connection with the vesting of restricted stock units awarded January 4, 2022.
F2 Includes 163,817 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units.